Effect of gamma-cyclodextrin, methanol and pH on the parameters of reversed-phase thin-layer chromatography of some antisense nucleotides

Journal of Inclusion Phenomena

Volumn 38, Issue 1-4, 2000, Pages 453-465

  Cserháti, Tibor ^a   Forgács, Esther ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Antisense nucleosides; pH effect; CD

Indexed keywords

EID: 0034360790     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1008158630533     Document Type: Article

References (27)

1. 1. S.T. Crooke: Antisense Nucl. Acid Drug Dev. 8, 115 (1998).
2. 2. G.D. Hoke, K. Draper, S.M. Freier, C. Gonzalez, V.B. Driver, MC. Zounes and D.J. Ecker: Nucl. Acid Res. 19, 5743 (1991).
3. 3. Y. Shoji, M. Norimatsu, J. Shimada, Y. Mizushi and Y. Mizushima: Antisense Nucl. Acid Drug Dev. 8, 255 (1998).
4. 4. L.S. Jeong, H.R. Moon, S.J. Yoo, S.N. Lee, H.-D. Kim and M.W. Chun: Nucleosides Nucleotides 18, 571 (1999).
5. 5. X. Zheng and V. Nair: Nucleosides Nucleotides 18, 1961 (1999).
6. 6. H.-M. Chen, R. Sood and R.S. Rosmane: Nucleosides Nucleotides 18, 331 (1999).
7. 7. C. Pichon, I. Freulon, P. Midoux, R. Mayer, M. Monsigny and A.C. Roche: Antisense Nucl. Acid Drug Dev. 7, 335 (1997).
8. 8. G.B. Takle, A.R. Thierry, S.M. Flynn, L. Peng, L. White, W. de Vonish, R.A. Galbraith, A.R. Goldberg and S.T. George: Antisense Nucl. Acid Drug Dev. 7, 177 (1997).
9. 9. H.P. Zobel, J. Kreuter, D. Werner, C.R. Noe, G. Kumel and A. Zimmer: Antisense Nucl. Acid Drug Dev. 1, 483 (1997).
10. 10. U. Maus, S. Rosseau, N. Mandrakas, R. Schlingensiepen, R. Maus, H. Muth, F. Grimmiger, W. Seeger and J. Lohmeyer: Antisense Nucl. Acid Drug Dev. 9, 71 (1999).
11. 11. J. Szejtli: Cyclodextrins and Their Inclusion Complexes, Akadémiai Kiadó, Budapest, Hugary (1982).
12. 12. J. Szejtli: Cyclodextrin Technology, Kluwer Academic Publishers, Dordrecht, The Netherlands (1989).
13. 13. W.J. Irwin, A.K. Dwivedi, P.A. Holbrook and M.J. Dey: Pharm. Res. 18, 1698 (1994).
14. 14. T. Loftsson, B. Jonsdottir, J. Baldwinsdottir and H. Fridriksdottir: STP Pharma Sci. 4, 354 (1994).
15. 15. T. Loftsson, A.M. Sigurdottir and J.H. Olafsson: Int. J. Pharm. 115, 245 (1995).
16. 16. A. Preiss, W. Mehnert and K.H. Fromming: Pharmazie 50, 121 (1995).
17. 17. Q.Y. Zhao, J. Temsamani and S. Agrawal: AntiSense Res. Dev. 5, 185 (1995).
18. 18. T. Cserháti, E. Forgács and J. Szejtli: Int. J. Pharm. 141, 1 (1996).
19. 19. T. Cserháti and K. Valkó: Chromatographic Determination of Molecular Interactions, CRC Press, Boca Raton, FL (1994).
20. 20. N. Sadley-Sosnowska: J. Chromatogr.A 728, 89 (1996).
21. 21. P. Gareil, D. Pernin, J.P. Grammond and F. Guyon: J. High Res. Chromatogr. 16, 195 (1993).
22. 22. M. Jung, D. Schmalzing and V. Schurig: J. Chromatogr. 552, 43 (1991).
23. 23. V. Lambroussi, S. Piperaki and A. Tsantili-Kakoulidou: J. Planar Chromatogr.-Mod. TLC 12, 124 (1999).
24. 24. J. Szejtli: in J. Szejtli and T. Osa (eds.), Comprehensive Supramolecular Chemistry, Vol. 3, Pergamon Press, UK, p. 189 (1996).
25. 25. A. Buvári, J. Szejtli and L. Barcza: J. Incl. Phenom. 1, 151 (1983/1984).
26. 26. A. Harada and S. Takahashi: Chem. Lett. 2089 (1984).
27. 27. T. Cserháti, E. Forgács and G. Sági J. Liq. Chrom. Rel. Technol. 22, 125 (1999).